Cannara Biotech Inc (LOVE) — Financial Flexibility Index
Cannara Biotech Inc (LOVE) has a Financial Flexibility Index of 0.20x as of November 2025. Free cash flow of CA$12.58 Million (operating CF CA$7.96 Million minus capex CA$4.62 Million) represents 0% of total liabilities (CA$62.63 Million). Check Cannara Biotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cannara Biotech Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Cannara Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see LOVE cash generation efficiency.
Annual Financial Flexibility Index for Cannara Biotech Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Cannara Biotech Inc. Explore Cannara Biotech Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CA$26.37 Million | CA$20.01 Million | CA$66.43 Million | ▲ +46.0% |
| 2024 | 0.27x | CA$18.15 Million | CA$10.68 Million | CA$66.77 Million | ▲ +6.4% |
| 2023 | 0.26x | CA$15.79 Million | CA$5.91 Million | CA$61.78 Million | ▲ +66.9% |
| 2022 | 0.15x | CA$9.02 Million | CA$-6.08 Million | CA$58.88 Million | ▼ -85.0% |
| 2021 | 1.02x | CA$28.51 Million | CA$-2.09 Million | CA$27.91 Million | ▲ +11872.3% |
| 2020 | -0.01x | CA$-143.08K | CA$-9.32 Million | CA$16.49 Million | ▼ -101.0% |
| 2019 | 0.86x | CA$15.60 Million | CA$-7.41 Million | CA$18.17 Million | ▼ -52.7% |
| 2018 | 1.81x | CA$25.61 Million | CA$-2.30 Million | CA$14.12 Million | — |